Skip to main content
eScholarship
Open Access Publications from the University of California

PI3Kγ is a molecular switch that controls immune suppression.

  • Author(s): Kaneda, Megan M
  • Messer, Karen S
  • Ralainirina, Natacha
  • Li, Hongying
  • Leem, Christopher J
  • Gorjestani, Sara
  • Woo, Gyunghwi
  • Nguyen, Abraham V
  • Figueiredo, Camila C
  • Foubert, Philippe
  • Schmid, Michael C
  • Pink, Melissa
  • Winkler, David G
  • Rausch, Matthew
  • Palombella, Vito J
  • Kutok, Jeffery
  • McGovern, Karen
  • Frazer, Kelly A
  • Wu, Xuefeng
  • Karin, Michael
  • Sasik, Roman
  • Cohen, Ezra EW
  • Varner, Judith A
  • et al.

Published Web Location

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479689/
No data is associated with this publication.
Abstract

Macrophages play critical, but opposite, roles in acute and chronic inflammation and cancer. In response to pathogens or injury, inflammatory macrophages express cytokines that stimulate cytotoxic T cells, whereas macrophages in neoplastic and parasitic diseases express anti-inflammatory cytokines that induce immune suppression and may promote resistance to T cell checkpoint inhibitors. Here we show that macrophage PI 3-kinase γ controls a critical switch between immune stimulation and suppression during inflammation and cancer. PI3Kγ signalling through Akt and mTor inhibits NFκB activation while stimulating C/EBPβ activation, thereby inducing a transcriptional program that promotes immune suppression during inflammation and tumour growth. By contrast, selective inactivation of macrophage PI3Kγ stimulates and prolongs NFκB activation and inhibits C/EBPβ activation, thus promoting an immunostimulatory transcriptional program that restores CD8+ T cell activation and cytotoxicity. PI3Kγ synergizes with checkpoint inhibitor therapy to promote tumour regression and increased survival in mouse models of cancer. In addition, PI3Kγ-directed, anti-inflammatory gene expression can predict survival probability in cancer patients. Our work thus demonstrates that therapeutic targeting of intracellular signalling pathways that regulate the switch between macrophage polarization states can control immune suppression in cancer and other disorders.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item